IJMS | Free Full-Text | The Efficacy of Tumor Mutation Burden as a Biomarker of Response to Immune Checkpoint Inhibitors
Systemic immunity in cancer | Nature Reviews Cancer
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy - ScienceDirect
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer - eBioMedicine
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
![PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ac5e5e50d735ecf3baed58f3854dd1fa050a509/4-Figure1-1.png "PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar")
PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar
Cells | Free Full-Text | Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
Frontiers | The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Frontiers | Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Perspectives of solid organ transplant recipients on medicine‐taking: Systematic review of qualitative studies - Tang - 2021 - American Journal of Transplantation - Wiley Online Library
Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy | Journal for ImmunoTherapy of Cancer
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities | Aging
H.R. 5534 Passed: Lifetime Medicare Coverage of Immunosuppressant for Kidney Recipients - American Transplant Foundation
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
Transplantology | Free Full-Text | Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ - ScienceDirect
Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance | npj Precision Oncology
Patient-centred approaches for the management of unpleasant symptoms in kidney disease | Nature Reviews Nephrology
Cancer Risk Among Immunosuppressed Populations - NCI
